Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class ASSE: 600513

Announcement on Unblinding Results of the Phase III Clinical Trial of Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin

· Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Unblinding Results of the Phase III Clinical Trial of Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis